| Scott Shadfar, MD | |
|
4509 Integris Pkwy Ste 350, Edmond, OK 73034-8696 | |
| (405) 657-3895 | |
| (405) 657-3896 |
| Full Name | Scott Shadfar |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 16 Years |
| Location | 4509 Integris Pkwy Ste 350, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710148283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | 31708 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Health Edmond | Edmond, OK | Hospital |
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integris Ambulatory Care Corporation | 2365408465 | 382 |
News Archive
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.
Multiple sclerosis is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known.
Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling plan.
› Verified 7 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.
Multiple sclerosis is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known.
Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling plan.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Shadfar, MD 3001 Quail Springs Pkwy Fl 5, Oklahoma City, OK 73134-2640 Ph: (405) 657-3895 | Scott Shadfar, MD 4509 Integris Pkwy Ste 350, Edmond, OK 73034-8696 Ph: (405) 657-3895 |
News Archive
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.
Multiple sclerosis is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known.
Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling plan.
› Verified 7 days ago
Emily Sue White, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4509 Integris Pkwy Ste 200, Edmond, OK 73034 Phone: 405-657-3950 Fax: 405-471-0040 | |
Dr. Erica Beth Romano, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4509 Integris Pkwy Ste 200, Edmond, OK 73034 Phone: 405-657-3436 Fax: 405-815-6130 | |
Mark W. Wood, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3824 S Boulevard Ste 160, Edmond, OK 73013 Phone: 405-607-7600 Fax: 405-607-3575 | |
Jonathan Martin Pillow, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3824 S Boulevard, Suite 160, Edmond, OK 73013 Phone: 405-562-1810 Fax: 405-562-1816 | |
Steven Craig Quattlebaum Ii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2017 W I 35 Frontage Rd Ste 140, Edmond, OK 73013 Phone: 405-757-3710 Fax: 405-757-3711 |